Moderna’s COVID vaccine — its lone commercial product — has brought in $10.4 billion in revenue this year while Pfizer’s vaccine brought in about $22 billion.

It argues that Pfizer and BioNtech's vaccine infringes patents Moderna filed between 2010 and 2016 for its messenger RNA or mRNA technology. All three companies' COVID-19 vaccines used mRNA ...

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents, in the latest round of a ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

In June, the U.S. Food and Drug Administration added a warning label to both Pfizer and Moderna’s COVID-19 vaccine of its potential risk for individuals to develop myocarditis and pericarditis.

The motion, brought forward by far-right lawmakers, was overwhelmingly defeated. A total of 360 MEPs voted against it, while 175 supported it and 18 abstained. Of the 720 members of the Parliament, ...

Researchers are ushering in a new era of vaccine design that promises to be faster, more precise, and capable of tackling humanity’s most stubborn diseases.

In January 2022, Pfizer CEO Albert Bourla said the company's two-dose vaccine offered limited or no protection against COVID-19.

Moderna is not asking that courts take the Pfizer-BioNTech COVID-19 vaccine off the market or to stop future sales, in view of the public need for the vaccines. Moderna and Pfizer's vaccines have ...

Pfizer and BioNTech's COVID-19 vaccine is 100% effective against the virus in children ages 12 to 15, the companies announced in a press release Wednesday.. In a placebo-controlled trial of 2,260 ...